Nachrichten zur Eli Lilly & Co. Aktie

Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a…

Key deals this week: Couchbase, Eli Lilly, NTT Data, QXO, US Steel and more

…

Lilly expects orforglipron obesity results in third quarter

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the…

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk…

Eli Lilly says India response to obesity drug Mounjaro is positive, will focus on meeting demand

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing…

Missed Out on Eli Lillys 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. @themotleyfool #stocks $VKTX $LLY $ALT

…

Missed Out on Eli Lillys 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years, thanks in large…

Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?

It wasnt so long ago that Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company, seemed to be firing on all…

Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly

VERV jumps on Eli Lillys buyout offer, adding next-gen gene-editing therapies to the pharma giants pipeline.…

Members of Congress Are Pouring Millions Into These 7 Surprising Stocks

In this video, I will review some of the stock purchases made by members of the U.S. Congress. Politicians such…

Eli Lilly Gets Into The Gene-Editing Space With $1 Billion Takeout

The companies were already collaborating on a handful of cardiovascular-focused gene-editing treatments.…

Lennar, Jabil, Nvidia

Wall Streets main indexes were on track for a lower open on Tuesday as the Israel-Iran conflict entered its fifth…

Eli Lilly: The Buy Case Gets Stronger (Rating Upgrade)

…

Eli Lilly lining up $1.3bn swoop for cholesterol specialist Verve

Eli Lilly and Co (NYSE:LLY) is in advanced discussions to acquire Verve Therapeutics in a deal worth up to $1.3…

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial…

Why Novo Nordisk Stock Sank by Nearly 4% Today

Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the…

Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Eli Lilly (LLY) stood at $807.58, denoting a -1.44% move from the…

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Youre unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night…

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical…

1 Growth Stock Down 9% to Buy Right Now

Not many companies that have been around since the late 1800s can claim that theyre growth companies. But Eli Lilly…

Top Analyst Reports for Eli Lilly, Home Depot & SAP

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company, The Home Depot and…

Down 12%, Should You Buy the Dip on Eli Lilly? @themotleyfool #stocks $LLY

…

Is This Stock a Buy After Acquiring a Potential Zepbound Competitor?

Shares of Regeneron (NASDAQ: REGN) have declined this year due to issues with one of its former growth drivers, Eylea,…

2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility

Broader equities have not performed particularly well in 2025. The S&P 500 is barely in the black year to date.…

Should You Buy Eli Lilly Stock Before June 22? @themotleyfool #stocks $LLY

…

Drug pricing reform talks with US government lack clarity, industry executives say

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how…

1 Stock Down 34% This Year to Buy and Hold

Shares of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, are down by 34% this year. This poor performance may suggest…

Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Years 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years

You dont have to be a billionaire to invest like one -- and reap the rewards. Any of us can…

Should You Invest $1,000 in Eli Lilly today?

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The…

Should You Invest $1,000 in Eli Lilly today? @themotleyfool #stocks $LLY $NVO $AMZN $GS $NVDA

…

Eli Lilly: Mit Milliardenprojekt in Deutschland auf Expansionskurs

Eli Lilly gehört zu den traditionsreichsten Pharmaunternehmen der USA und hat sich in den vergangenen Jahren verstärkt auf wachstumsstarke Bereiche…

Eli Lilly, Camurus in major deal to develop obesity, diabetes drugs

…

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

· Partnership focused on development of long-acting therapies based on Camurus’ FluidCrystal[®] technology and Eli Lilly’s proprietary drug compounds …

Could Viking Therapeutics Become the Next Eli Lilly?

The obesity treatment market is booming, with groundbreaking drugs like Eli Lillys (NYSE: LLY) Zepbound delivering transformative patient results and…

Weight Loss Drug ETF (THNR) Hits New 52-Week High

THNR hits a 52-week high, fueled by gains in Eli Lilly and Novo Nordisk -- could the rally still have…

Key deals this week: EOG Resources, VivoPower, Servotronics, Eli Lilly and more

…

2 Top Stocks to Buy With Less Than $100

When investing on a budget, buying fractional shares of top companies is one option. Another is to find stocks with…

3 American Growth Giants to Invest in for the Long Haul

Many of the best growth stocks in the world are based out of the U.S. This is the land of…

2 Beaten-Down Stocks to Buy on the Dip

It wont come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this…

Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer

LLY inks $1B deal to acquire SiteOne, adding phase II-ready pain drug STC-004 to strengthen its neuroscience pipeline.…

Eli Lilly greift nach Zukunft der Schmerzmedizin! SiteOne Therapeutics Deal soll Opioid-Alternativen vorantreiben!

Der Pharmariese Eli Lilly (LLY) übernimmt laut einer Pressemitteilung vom Dienstag, den 27. Mai 2025, das Privatunternehmen SiteOne Therapeutics und…

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…

Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said…

Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition

Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…

Eli Lilly expands neuroscience pipeline with $1B acquisition of SiteOne therapeutics

Eli Lilly and Co (NYSE:LLY) announced it is acquiring SiteOne Therapeutics, a private biotech firm developing small-molecule inhibitors of sodium…

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics By Investing.com

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics…

Prediction: These 2 Stocks Will Beat the Market in the Next Decade

Investors typically want to beat the market over the long run. Though its not an easy task, it certainly is…

Investing for the Long Term: 1 Unstoppable Vanguard ETF to Buy and Hold Forever

The Vanguard Growth ETF (NYSEMKT: VUG) is an exchange-traded fund (ETF) that exclusively holds large-cap stocks. It has outperformed the…

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…

Cigna takes different approach with GLP-1s, more favorable for Eli Lilly By Investing.com

Cigna takes different approach with GLP-1s, more favorable for Eli Lilly…